div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: BC Cancer · 2016 6 20 · for the Oncotype DX assay is generally subject to the regulations applicable in the patients country of residence if no reimbursement or cost coverage src=https:reader036vdocumentinreader036viewer2022062607604744442de1a32a10479299html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: BC Cancer · 2016 6 20 · for the Oncotype DX assay is generally subject to the regulations applicable in the patients country of residence if no reimbursement or cost coverage src=https:reader036vdocumentinreader036viewer2022062607604744442de1a32a10479299html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdiv